Masoud Vedadi

18.5k total citations · 1 hit paper
141 papers, 9.7k citations indexed

About

Masoud Vedadi is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Masoud Vedadi has authored 141 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Infectious Diseases. Recurrent topics in Masoud Vedadi's work include Epigenetics and DNA Methylation (62 papers), Cancer-related gene regulation (59 papers) and RNA modifications and cancer (24 papers). Masoud Vedadi is often cited by papers focused on Epigenetics and DNA Methylation (62 papers), Cancer-related gene regulation (59 papers) and RNA modifications and cancer (24 papers). Masoud Vedadi collaborates with scholars based in Canada, United States and United Kingdom. Masoud Vedadi's co-authors include H. Berglund, F. Niesen, C.H. Arrowsmith, Abdellah Allali‐Hassani, Fengling Li, Guillermo Senisterra, Peter J. Brown, Jinrong Min, Matthieu Schapira and Dalia Baršytė-Lovejoy and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Masoud Vedadi

139 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

2007 1.9k citations F. Niesen, H. Berglund et al. profile →

Peers

Countries citing papers authored by Masoud Vedadi

Since Specialization

Citations

This map shows the geographic impact of Masoud Vedadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Vedadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Vedadi more than expected).

Fields of papers citing papers by Masoud Vedadi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Vedadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Vedadi. The network helps show where Masoud Vedadi may publish in the future.

Co-authorship network of co-authors of Masoud Vedadi

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Vedadi. A scholar is included among the top collaborators of Masoud Vedadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Vedadi. Masoud Vedadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kinetic characterization of human mRNA guanine-N7 methyltransferase 2024 ·Scientific Reports ·Sumera Perveen, Aliakbar Khalili Yazdi, Taraneh Hajian, Fengling Li, Masoud Vedadi	2
2	Development of Peptide Displacement Assays to Screen for Antagonists of DDB1 Interactions 2024 ·Biochemistry ·(unknown), Shabbir Ahmad, Mark Mabanglo, Levon Halabelian, Matthieu Schapira, Suzanne Ackloo, Sumera Perveen, Pegah Ghiabi, Masoud Vedadi	2
3	Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2 2023 ·Journal of the American Chemical Society ·Ronan P. Hanley, Yan Nie, (unknown), Fengling Li, Amin Sobh, Chenxi Xu, Natalie K. Barker, David Dilworth, Taraneh Hajian, Elisa Gibson, Magdalena M. Szewczyk, Peter J. Brown, Dalia Baršytė-Lovejoy, Laura E. Herring, Gang Greg Wang, Jonathan D. Licht, Masoud Vedadi, C.H. Arrowsmith, Lindsey I. James	32
4	The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition 2023 ·Communications Biology ·Serah Kimani, Sumera Perveen, (unknown), Hong Zeng, Aiping Dong, Fengling Li, Pegah Ghiabi, Yanjun Li, Irene Chau, C.H. Arrowsmith, Dalia Baršytė-Lovejoy, Vijayaratnam Santhakumar, Masoud Vedadi, Levon Halabelian	12
5	SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1 2023 ·Proceedings of the National Academy of Sciences ·Zifeng Wang, Jessica Petricca, (unknown), (unknown), Sujun Chen, (unknown), (unknown), Susan Patalano, (unknown), Kellee R. Siegfried, Jill A. Macoska, Dong Han, Shuai Gao, Masoud Vedadi, C.H. Arrowsmith, Housheng Hansen He, Changmeng Cai	9
6	Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Victoria Vu, Fengling Li, Abdellah Allali‐Hassani, Albina Bolotokova, Frédéric Allemand, Muriel Gelin, Philippe Cotelle, Simon Woo, Steven R. LaPlante, Dalia Baršytė-Lovejoy, Vijayaratnam Santhakumar, Masoud Vedadi, Jean‐François Guichou, Borhane Annabi, Alexandre Gagnon	8
7	Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration 2023 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), Victoria Vu, Fengling Li, Abdellah Allali‐Hassani, (unknown), Magdalena M. Szewczyk, Albina Bolotokova, Frédéric Allemand, Muriel Gelin, Dalia Baršytė-Lovejoy, Vijayaratnam Santhakumar, Masoud Vedadi, Jean‐François Guichou, Borhane Annabi, Alexandre Gagnon	9
8	Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors 2023 ·ACS Omega ·(unknown), Dominika Chalupská, Karel Chalupský, (unknown), (unknown), Petra Krafčíková, (unknown), Michal Šála, Milan Dejmek, (unknown), (unknown), Jaroslav Kozák, (unknown), Masoud Vedadi, Jan Weber, Helena Mertlíková‐Kaiserová, Radim Nencka	13
9	Discovery of Nedd4 auto-ubiquitination inhibitors 2023 ·Scientific Reports ·(unknown), (unknown), Pegah Ghiabi, Vijayaratnam Santhakumar, Masoud Vedadi	5
10	Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors 2022 ·ACS Infectious Diseases ·Aliakbar Khalili Yazdi, (unknown), Sumera Perveen, Taraneh Hajian, Vijayaratnam Santhakumar, Albina Bolotokova, Fengling Li, Masoud Vedadi	14
11	Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics** 2021 ·ChemMedChem ·(unknown), Alice Li, (unknown), Dimitrios Panagopoulos, Fengling Li, Magdalena M. Szewczyk, David Smil, (unknown), (unknown), Timo Stellfeld, C.H. Arrowsmith, Dalia Barsyte, Masoud Vedadi, Ingo V. Hartung, H. Steuber, Robert Britton, Vijayaratnam Santhakumar	11
12	Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells 2020 ·Journal of Biological Chemistry ·(unknown), (unknown), (unknown), Roberta Mazzone, (unknown), Irene del Molino del Barrio, Annalidia Donato, (unknown), Fengling Li, Masoud Vedadi, Andrea H. Németh, Paul E. Brennan, Richard Wade‐Martins	9
13	Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain 2019 ·Journal of Medicinal Chemistry ·Mandeep Mann, Ivan Franzoni, Renato Ferreira de Freitas, W. Tempel, Scott Houliston, (unknown), Masoud Vedadi, C.H. Arrowsmith, Rachel Harding, Matthieu Schapira	10
14	Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7 2017 ·Angewandte Chemie ·(unknown), Stephen Wolstenhulme, Anthony Tumber, Stephanie B. Hatch, Yijia Zhang, Susanne Müller, Shane A. Chandler, Barbara Mair, Fengling Li, Sebastian Nijman, Rebecca Konietzny, Tamás Szommer, Clarence Yapp, Oleg Fedorov, Justin L. P. Benesch, Masoud Vedadi, Benedikt M. Kessler, Akane Kawamura, Paul E. Brennan, Martin D. Smith	1
15	Discovery of a Highly Selective Cell‐Active Inhibitor of the Histone Lysine Demethylases KDM2/7 2017 ·Angewandte Chemie International Edition ·(unknown), Stephen Wolstenhulme, Anthony Tumber, Stephanie B. Hatch, Yijia Zhang, Susanne Müller, Shane A. Chandler, Barbara Mair, Fengling Li, Sebastian Nijman, Rebecca Konietzny, Tamás Szommer, Clarence Yapp, Oleg Fedorov, Justin L. P. Benesch, Masoud Vedadi, Benedikt M. Kessler, Akane Kawamura, Paul E. Brennan, Martin D. Smith	33
16	Structure-activity relationship studies of G9a-like protein (GLP) inhibitors 2017 ·Bioorganic & Medicinal Chemistry ·Yan Xiong, Fengling Li, Nicolas Babault, Hong Wu, Aiping Dong, Hong Zeng, Xin Chen, C.H. Arrowsmith, Peter J. Brown, Jing Liu, Masoud Vedadi, Jian Jin	26
17	Thermal Denaturation Assays in Chemical Biology 2011 ·Assay and Drug Development Technologies ·Guillermo Senisterra, Irene Chau, Masoud Vedadi	108
18	A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors 2010 ·Molecular BioSystems ·Amy Quinn, Abdellah Allali‐Hassani, Masoud Vedadi, Anton Simeonov	43
19	Methylation-state-specific recognition of histones by the MBT repeat protein L3MBTL2 2009 ·Nucleic Acids Research ·Yahong Guo, Nataliya Nady, Chao Qi, Abdellah Allali‐Hassani, Haizhong Zhu, Patricia W. Pan, Melanie A. Adams-Cioaba, M.F. Amaya, Aiping Dong, Masoud Vedadi, Matthieu Schapira, Randy J. Read, C.H. Arrowsmith, Jinrong Min	73
20	Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination 2006 ·Proceedings of the National Academy of Sciences ·Masoud Vedadi, F. Niesen, Abdellah Allali‐Hassani, O. Fedorov, P.J. Finerty, Gregory A. Wasney, (unknown), C.H. Arrowsmith, Linda Ball, H. Berglund, Raymond Hui, Brian D. Marsden, P. Nordlund, M. Sundström, Johan Weigelt, A.M. Edwards	471

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact